Gardasil 9 syringe 10S
Ended Awarded Last action
- Contract number
- SPE2DR26FW9RZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $93,723
Award facts
- Contract value 100% obligated
- $93,722.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $93,722.79 to AmerisourceBergen Drug Corp for Gardasil 9 syringes (10-count packages) with a firm fixed-price structure. The order was competitively awarded without set-aside designation and is scheduled for completion by February 5, 2026. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor supporting federal medical procurement requirements across the Defense Health System. The Gardasil 9 vaccine syringes being procured under this delivery order support routine immunization programs for military personnel and beneficiaries. As a major pharmaceutical distributor, AmerisourceBergen demonstrates consistent capability to fulfill federal medical supply requirements through open and competitive procurement processes, with its contract portfolio encompassing a comprehensive range of medications, vaccines, and medical devices across multiple therapeutic domains. The company's role as a prime vendor under the DLA's pharmaceutical support contract reflects its significance in the federal medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FW9RZ?
SPE2DR26FW9RZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FW9RZ worth?
The government has obligated $93,723 on SPE2DR26FW9RZ.
Is contract SPE2DR26FW9RZ an order under another contract?
Yes. SPE2DR26FW9RZ is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FW9RZ competed?
The extent of competition for SPE2DR26FW9RZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award